Professor Mark Chambers


Professor of Microbiology and Disease Intervention, Head of Department of Microbial Sciences
BSc (Hons), PhD (Cantab)
+44 (0)1483 689182
01 VSM 02
Mondays to Thursdays, 9am to 6pm
Emily Handford
01483 682516

Biography

Areas of specialism

Antimicrobial Resistance; Tissue culture models; Animal replacement

University roles and responsibilities

  • Head of Department of Microbial Sciences
  • Member of the Steering Committee for the Comparative Pathology Clinical Academic Group.
  • Member of the NASPA Sub-Committee.
  • Member of the Board of Studies for Veterinary Microbiology MSc.
  • Member of the University Biological Safety Committee.

    My qualifications

    1989
    PhD
    University of Cambridge

    Previous roles

    2013 - 2020
    Professor of Veterinary Bacteriology
    University of Surrey
    1996 - 2020
    R&D Project Leader
    Animal and Plant Health Agency

    Research

    Research interests

    Research projects

    Research collaborations

    My teaching

    My publications

    Publications

    Mary-Anne Frank, William S M Justice, Roberto La Ragione, Mark A Chambers (2021)ANTIBIOTIC RESISTANCE IN ESCHERICHIA COLI AND ENTEROCOCCUS SPP. ISOLATED FROM UNGULATES AT A ZOOLOGICAL COLLECTION IN THE UNITED KINGDOM, In: Journal of Zoo and Wildlife Medicine51(4)pp. 761-770 American Association of Zoo Veterinarians
    Increase of antimicrobial resistance (AMR) is a global threat to health. The AMR profile of bacteria isolated from domesticated animals and free-ranging wildlife has been studied, but there are relatively few studies of bacteria isolated from captive wild animals. Understanding the dynamics of AMR in different populations is key to minimizing emergence of resistance and to preserve the efficacy of antimicrobials. In this study, fecal samples were collected from 17 species of healthy ungulates from a zoological collection in southeast England, which yielded 39 and 55 spp. isolates for further analysis. Antibiotic sensitivity was investigated using agar disk diffusion. isolates were resistant to a range of antibiotics, with resistance to ampicillin being the most common (28%). All isolates were susceptible to apramycin, enrofloxacin, chloramphenicol, and florfenicol. None tested positive for extended-spectrum beta-lactamase or AmpC activity. Seven of 39 (18%) isolates were resistant to three or more antibiotic classes. The isolates were further analyzed using multilocus sequence typing, which identified four pairs of identical sequence type isolates and 27 diverse strains. The spp. isolates were resistant to a range of antibiotics, with resistance to cefpodoxime seen in 95% of isolates. All spp. isolates were susceptible to ampicillin, gentamicin, chloramphenicol, and vancomycin. This study identified multidrug-resistant phenotypes in enterobacterial isolates that were like those commonly found in domestic ungulates. There was no apparent spatial clustering of the resistance profiles within the zoo. Review of the medical records of individual animals showed no direct relation to the AMR profiles observed. Observed resistance to antibiotics rarely or never used may have been due to coselection or directly acquired from other sources.
    Alastair S Macdonald, Mark A Chambers, Roberto La Ragione, Kayleigh Wyles, Matthieu Poyade, Andrew Wales, Naomi Klepacz, Tom R Kupfer, Fraje Watson, Shona Noble (2021)Addressing Infection Risk in Veterinary Practice through the Innovative Application of Interactive 3D Animation Methods, In: The Design Journal24(1)pp. 51-72 Routledge
    Antimicrobial resistance is of growing concern in human and animal health. The aim of this study was to raise awareness and perception of risk of infection-related behaviours during routine preparation for veterinary surgery. We took a multi-disciplinary and multi-method approach to 'make visible, the invisible' by illustrating how microbial contamination can be spread during the preparation process for surgical procedures. The design-led visualization approach enhanced inter-disciplinary team and workshop participant contributions during the co-development of an innovative digital tool to support training for veterinary practitioners and students. After experiencing the intervention, 92% of 51 participants agreed to change their behaviour and stated an intention to implement an infection control behaviour that aligned with training objectives. The 3D graphics enhanced the delivery of training content by making difficult and abstract contamination concepts easy to understand. A similar approach could be taken for human health applications.
    Anna Stedman, Arnoud van Vliet, Mark Chambers, Jorge Gutierrez Gut commensal bacteria show beneficial properties as wildlife probiotics, In: Annals of the New York Academy of Sciences New York Academy of Sciences
    Probiotics represent a non-invasive, environmentally-friendly alternative to reduce infectious diseases in wildlife species. Our aim was to evaluate the potential of typical gut commensals, such as lactic acid bacteria (LAB), as wildlife probiotics. The selected LAB were isolated from European badgers (Meles meles); a wildlife reservoir of bovine tuberculosis, and comprised four different genera: Enterococcus; Weissella; Pediococcus; and Lactobacillus. The enterococci displayed a phenotype and genotype that correlate with the production of antibacterial peptides and stimulation of antiviral responses. However, these isolates carry virulence and antibiotic resistance genes. Weissella showed some anti-mycobacterial activity due to their ability to produce lactate and ethanol. Interestingly, lactobacilli and pediococci modulated pro-inflammatory phagocytic responses that associate with protection against pathogens; and these responses agreed with the presence of immunomodulatory markers in their genomes. Although both lactobacilli and pediococci showed tolerance to antibiotics, this resistance was naturally acquired and almost all isolates possessed a strong phylogenetic relationship with isolates from food and healthy animals. Our results show that LAB display probiotic benefits that depend on the genera. Lactobacilli and pediococci are probably the most interesting candidates as probiotics against infectious diseases in wildlife because of their food-grade status and ability to modulate protective innate immune responses.
    Jordan Pascoe, Charlotte L. Hendon-Dunn, Colin P.D. Birch, Gareth A. Williams, Mark A. Chambers, Joanna Bacon (2020)Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival, In: Pharmaceutics12(9)pp. 1-14 MDPI
    Mycobacterium bovis Bacillus Calmette–Guérin (M. bovis BCG) was generated over a century ago for protection against Mycobacterium tuberculosis (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pellicle growth method, which is a complex and lengthy process that has been challenging to standardise. Fermentation for BCG vaccine production would reduce the complexity associated with pellicle growth and increase batch to batch reproducibility. This more standardised growth lends itself to quantification of the total number of bacilli in the BCG vaccine by alternative approaches, such as flow cytometry, which can also provide information about the metabolic status of the bacterial population. The aim of the work reported here was to determine which batch fermentation conditions and storage conditions give the most favourable outcomes in terms of the yield and stability of live M. bovis BCG Danish bacilli. We compared different media and assessed growth over time in culture, using total viable counts, total bacterial counts, and turbidity throughout culture. We applied fluorescent viability dyes and flow cytometry to measure real-time within-culture viability. Culture samples were stored in different cryoprotectants at different temperatures to assess the effect of these combined conditions on bacterial titres. Roisin’s minimal medium and Middlebrook 7H9 medium gave comparable, high titres in fermenters. Flow cytometry proved to be a useful tool for enumeration of total bacterial counts and in the assessment of within-culture cell viability and cell death. Of the cryoprotectants evaluated, 5% (v/v) DMSO showed the most significant positive effect on survival and reduced the negative effects of low temperature storage on M. bovis BCG Danish viability. In conclusion, we have shown a reproducible, more standardised approach for the production, evaluation, and storage of high titre, viable, BCG vaccine.
    MA Chambers, AO Whelan, R Spallek, M Singh, B Coddeville, Y Guerardel, E Elass (2010)Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9, In: Biochemical and Biophysical Research Communications400pp. 403-408
    Tom R. Kupfer, Kayleigh J. Wyles, Fraje Watson, Roberto Marcello La Ragione, Mark A. Chambers, Alastair S. Macdonald (2019)Determinants of hand hygiene behaviour based on the Theory of Interpersonal Behaviour, In: Journal of Infection Prevention Sage Publications
    Background: Many investigations into the determinants of hand hygiene (HH) behaviour have explored only individual predictors or were designed according to arguably overly simplistic models of behaviour. Consequently, important influences on HH behaviour, including habit and emotion, are sometimes neglected. This study is the first to employ the Theory of Interpersonal Behaviour as a comprehensive model for understanding the determinants of HH behaviour. Method: A self-report questionnaire was conducted with staff from two large UK veterinary referral practices. Participants (n = 75) reported their HH behaviour and responded to statements rating the importance of social norms, self-protection, patient protection, time pressures, access to equipment, habit and disgust, to their HH behaviour. Results: Regression analysis showed that, overall, determinants explained 46% of variance (p < .001) in self-reported HH behaviour, with time constraints being the strongest predictor (β = −.47, p < .001) followed by difficulty finding equipment (β = −.21, p = .05). Discussion: Time constraints may be the most important influence on HH adherence among the determinants investigated. Future researchers should consider employing theoretical models to aid a more comprehensive understanding of the psychology underlying HH adherence and HH interventions.
    M CHAMBERS, T CRAWSHAW, S WATERHOUSE, R DELAHAY, R HEWINSON, K LYASHCHENKO (2008)Validation of the BrockTB stat-pak assay for detection of tuberculosis in Eurasian badgers (Meles meles) and influence of disease severity on diagnostic accuracy, In: JOURNAL OF CLINICAL MICROBIOLOGY46pp. 1498-1500
    Needle-free methods of vaccination may allow rapid, simple and safe vaccination of large populations. Oral vaccination is the best established method but faces the hurdle of oral tolerance to the vaccine antigen. Skin-based transcutaneous immunization (TCI) offers an alternative needle-free route of vaccination that is able to induce protective immunity without the problem of oral tolerance. Helicobacter pylori is an important human pathogen associated with a number of gastrointestinal disorders, including gastritis, peptic ulcers and gastric tumors. Conventional treatments involving the use of antibiotics have a number of limitations and the development of an effective vaccine is the best long-term treatment option. A variety of experimental vaccines to Helicobacter have been reported. The paper reviewed here combines the approach of TCI with the use of a novel lipid antigen delivery system, hitherto only used for oral vaccination, to evaluate the potential for TCI for a simple vaccination strategy against Helicobacter and potentially other disease-causing organisms.
    MA Chambers, KP Lyashchenko, R Greenwald, J Esfandiari, E James, L Barker, J Jones, G Watkins, S Rolfe (2010)Evaluation of a Rapid Serological Test for the Determination of Mycobacterium bovis Infection in Badgers (Meles meles) Found Dead, In: Clinical and Vaccine Immunology17pp. 408-411
    Between October 2005 and May 2006, a total of 727 badgers found dead in Wales were reported, and 550 were delivered to the Regional Laboratories of the Veterinary Laboratories Agency (VLA). Of the 459 carcasses suitable for examination, 55 were deemed to be infected with Mycobacterium bovis on the basis of culture, spoligotyping, and variable-number tandem repeat typing. Acid-fast bacteria were observed histologically in a further six badgers, but these bacteria were not confirmed as M. bovis by culture. A rapid serological test (BrockTB Stat-Pak) performed on thoracic blood showed a sensitivity of 35% and a specificity of 99%. Presence of M. bovis infection was 45 times more likely to be confirmed postmortem by culture in BrockTB Stat-Pak-reactive animals than in seronegative ones. Using visible carcass lesions as a marker of bovine tuberculosis (bTB) infection had a similar sensitivity (38%) but was significantly less specific (84%) than serology. The overall accuracy of the antibody detection was 93% ( 346 correct results from 374 tests), whereas the accuracy of regarding visible lesions as a marker for bTB infection was 78% ( 354 correct from 453 carcasses examined). Culture remains the gold standard method for detecting M. bovis infection in badgers. However, where resources are limited and/or an instant result is preferred, the BrockTB Stat-Pak could be used in field surveillance efforts to identify animals which should be examined further by only submitting test-negative animals to more detailed postmortem examination and culture.
    Deanna Dalley, Sandrine Lesellier, Francisco J. Salguero, Mark A. Chambers (2019)Purification and Characterisation of Badger IgA and Its Detection in the Context of Tuberculosis, In: Veterinary Sciences6(4)pp. 89-99 MDPI
    European badgers are a wildlife reservoir of bovine tuberculosis in parts of Great Britain. Accurate diagnosis of tuberculosis in badgers is important for the development of strategies for the control of the disease. Sensitive serological tests for badger TB are needed for reasons such as cost and simplicity. Assay of mucosal IgA could be useful for diagnosing respiratory pathogens such as Mycobacterium bovis and for monitoring the response to mucosal vaccination. To develop an IgA assay, we purified secretory IgA from badger bile, identifying secretory component (SC), heavy chain (HC) and light chain (LC), at 66, 46 and 27 Kda, respectively, on the basis of size comparison with other species. Monoclonal antibodies (mAbs) were generated to purified IgA.We selected two for ELISA development. The detection limit of the IgA-specific mAbs was found to be approximately 20 ng/mL when titrated against purified badger bile. One monoclonal antibody specific for badger IgA was used to detect IgA in serum and tracheal aspirate with specificity to an immunodominant antigen of M. bovis. An M. bovis infection dose-dependent IgA response was observed in experimentally infected badgers. IgA was also detected by immunohistochemistry in the lungs of bTB-infected badgers. With further characterisation, these represent new reagents for the study of the IgA response in badgers.
    D GAVIER-WIDEN, M COOKE, J GALLAGHER, M CHAMBERS, C GORTAZAR (2009)A review of infection of wildlife hosts with Mycobacterium bovis and the diagnostic difficulties of the 'no visible lesion' presentation, In: NEW ZEALAND VETERINARY JOURNAL57pp. 122-131
    S Gowtage, GA Williams, R Henderson, P Aylett, D MacMorran, S Palmer, A Robertson, S Lesellier, SP Carter, Mark Chambers (2017)Testing of a palatable bait and compatible vaccine carrier for the oral vaccination of European badgers (Meles meles) against tuberculosis, In: Vaccine35(6)pp. 987-992 Elsevier
    The oral vaccination of wild badgers (Meles meles) with live Bacillus Calmette–Guérin (BCG) is one of the tools being considered for the control of bovine tuberculosis (caused by Mycobacterium bovis) in the UK. The design of a product for oral vaccination requires that numerous, and often competing, conditions are met. These include the need for a highly palatable, but physically stable bait that will meet regulatory requirements, and one which is also compatible with the vaccine formulation; in this case live BCG. In collaboration with two commercial bait companies we have developed a highly attractive and palatable bait recipe designed specifically for European badgers (Meles meles) that meets these requirements. The palatability of different batches of bait was evaluated against a standardised palatable control bait using captive badgers. The physical properties of the bait are described e.g. firmness and colour. The microbial load in the bait was assessed against European and US Pharmacopoeias. The bait was combined with an edible vaccine carrier made of hydrogenated peanut oil in which BCG vaccine was stable during bait manufacture and cold storage, demonstrating <0.5 log10 reduction in titre after 117 weeks’ storage at −20 °C. BCG stability in bait was also evaluated at +4 °C and under simulated environmental conditions (20 °C, 98% Relative Humidity; RH). Finally, iophenoxic acid biomarkers were utilised as a surrogate for the BCG vaccine, to test variants of the vaccine-bait design for their ability to deliver biomarker to the gastrointestinal tract of individual animals. These data provide the first detailed description of a bait-vaccine delivery system developed specifically for the oral vaccination of badgers against Mycobacterium bovis using live BCG.
    S LESELLIER, L CORNER, E COSTELLO, P SLEEMAN, K LYASHCHENKO, R GREENWALD, J ESFANDIARI, M SINGH, R HEWINSON, M CHAMBERS, E GORMLEY (2008)Antigen specific immunological responses of badgers (Meles meles) experimentally infected with Mycobacterium bovis, In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY122pp. 35-45
    A Balseiro, O Rodríguez, P González-Quirós, I Merediz, IA Sevilla, D Davé, DJ Dalley, S Lesellier, MA Chambers, J Bezos, M Muñoz, RJ Delahay, C Gortázar, JM Prieto (2011)Infection of Eurasian badgers (Meles meles) with Mycobacterium bovis and Mycobacterium avium complex in Spain, In: Vet J190pp. e21-e25
    The prevalence, distribution and pathology related to infection with Mycobacterium bovis and other mycobacteria were determined in trapped (n=36) and road-killed (n=121) badgers in Spain from 2006 to 2010. The prevalence of M. bovis based on bacteriological culture from road-killed badgers was 8/121 (6.6%) and from trapped badgers was 0/36 (0%). Tuberculosis/M. bovis infection was evident in 15/121 (12.4%) road-killed badgers when bacteriology and histopathology were combined. Mycobacterium avium complex was isolated by culture from the tracheal aspirate of 1/36 (2.8%) trapped badgers and from tissue pools from 8/121 (6.6%) road-killed badgers.
    JA Tree, S Smith, N Baker, S Clark, FE Aldwell, M Chambers, A Williams, PD Marsh (2012)Method for assessing IFN-? responses in guinea pigs during TB vaccine trials, In: Letters in Applied Microbiology55pp. 295-300
    Sandrine Lesellier, Colin P. D. Birch, Dipesh Davé, Deanna Dalley, Sonya Gowtage, Simonette Palmer, Claire McKenna, Gareth A. Williams, Roland Ashford, Ute Weyer, Sarah Beatham, Julia Coats, Alex Nunez, Pedro Sanchez-Cordon, John Spiropoulos, Stephen Powell, Jason Sawyer, Jordan Pascoe, Charlotte Hendon-Dunn, Joanna Bacon, Mark A. Chambers (2020)Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine Delivery, In: Pharmaceutics12(8) MDPI
    Bovine tuberculosis (TB) in Great Britain adversely affects animal health and welfare and is a cause of considerable economic loss. The situation is exacerbated by European badgers (Meles meles) acting as a wildlife source of recurrent Mycobacterium bovis infection to cattle. Vaccination of badgers against TB is a possible means to reduce and control bovine TB. The delivery of vaccine in oral bait holds the best prospect for vaccinating badgers over a wide geographical area. There are practical limitations over the volume and concentration of Bacillus of Calmette and Guérin (BCG) that can be prepared for inclusion in bait. The production of BCG in a bioreactor may overcome these issues. We evaluated the efficacy of oral, bioreactor-grown BCG against experimental TB in badgers. We demonstrated repeatable protection through the direct administration of at least 2.0 × 108 colony forming units of BCG to the oral cavity, whereas vaccination via voluntary consumption of bait containing the same preparation of BCG did not result in demonstrable protection at the group-level, although a minority of badgers consuming bait showed immunological responses and protection after challenge equivalent to badgers receiving oral vaccine by direct administration. The need to deliver oral BCG in the context of a palatable and environmentally robust bait appears to introduce such variation in BCG delivery to sites of immune induction in the badger as to render experimental studies variable and inconsistent.
    Sandrine Lesellier, Maria-Laura Boschiroli, Jacques Barrat, Christoph Wanke, Francisco J. Salguero, Waldo Garcia-Jimenez, Alex Nunez, Ana Godinho, John Spiropoulos, Simonette Palmer, Dipesh Dave, Paul Anderson, Jean-Marc Boucher, Krystel de Cruz, Sylvie Henault, Lorraine Michelet, Sonya Gowtage, Gareth A. Williams, Allan K. Nadian, Elodie Monchâtre-Leroy, Frank Boué, Mark A. Chambers, Céline Richomme (2019)Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileum, In: BMC Veterinary Research(15)445 BioMed Central

    Background

    Oral vaccination with Mycobacterium bovis Bacille of Calmette and Guerin (BCG) has provided protection against M. bovis to badgers both experimentally and in the field. There is also evidence suggesting that the persistence of live BCG within the host is important for maintaining protection against TB. Here we investigated the capacity of badger inductive mucosal sites to absorb and maintain live BCG. The targeted mucosae were the oropharyngeal cavity (tonsils and sublingual area) and the small intestine (ileum).


    Results

    We showed that significant quantities of live BCG persisted within badger in tissues of vaccinated badgers for at least 8 weeks following oral vaccination with only very mild pathological features and induced the circulation of IFNγ-producing mononuclear cells. The uptake of live BCG by tonsils and drainage to retro-pharyngeal lymph nodes was repeatable in the animal group vaccinated by oropharyngeal instillation whereas those vaccinated directly in the ileum displayed a lower frequency of BCG detection in the enteric wall or draining mesenteric lymph nodes. No faecal excretion of live BCG was observed, including when BCG was delivered directly in the ileum.


    Conclusions

    The apparent local loss of BCG viability suggests an unfavorable gastro-enteric environment for BCG in badgers, which should be taken in consideration when developing an oral vaccine for use in this species.

    Alistair Macdonald, Mark Chambers, Roberto La Ragione, Kayleigh Wyles, Matthieu Poyade, Andrew Wales, Naomi Klepacz, Tom Kupfer, Fraje Watson, Shona Noble (2020)Using novel visualisation methods to combat infection risk during clinical practices., In: Proceedings of the 6th International Conference on Design4Health
    A Tomlinson, M Chambers, R Delahay (2012)Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease, In: Veterinary Immunology and Immunopathology148pp. 326-330
    J SAWYER, D MEALING, D DALLEY, D DAVE, S LESELLIER, S PALMER, J BOWEN-DAVIES, T CRAWSHAW, M CHAMBERS (2007)Development and evaluation of a test for tuberculosis in live European badgers (Meles meles) based on measurement of gamma interferon mRNA by real-time PCR, In: JOURNAL OF CLINICAL MICROBIOLOGY45pp. 2398-2403

    Background

    An oral vaccine is a potential tool to tackle the reservoir of Mycobacterium bovis in European badgers (Meles meles), which contributes to tuberculosis of cattle in the British Isles. Inferences about vaccine protection against experimental challenge with M. bovis depend on the measurement of tuberculosis. Assessment of tuberculosis in larger species, such as badgers, is typically based on the tuberculous lesions visible at post-mortem examination and histopathology. We have developed a robust scoring system for tuberculous lesions by combining several parallel measures, which we call the “disease burden score” (DBS).


    Methods

    Alternative scoring systems were compared within a regression analysis applied to observations from a total of 168 badgers from eight studies, including 107 badgers subjected to vaccination treatment and 61 non-vaccinated controls. The analysis included incidental observations that were recorded from each badger as potential covariate factors explaining some of the variation among animals sourced from the wild.


    Results

    DBS was found to be the most accurate and reliable of the scoring systems compared. By taking account of significant covariates affecting disease, application of the DBS reduced residual variance by 22.9%. A previously used measure, based on assessment of visible lesions, was suboptimal due to non-uniform variance that increased with expected value, although square root transformation addressed this issue. The covariate model fitted to DBS included sex (males had higher DBS), weight (negatively associated with DBS) and immunological evidence of prior exposure to Mycobacterium avium (positively associated with DBS).


    Conclusions

    We identified improved measures of tuberculous disease derived from data already collected. We also demonstrated that the proper scaling of measurements of disease in such models is necessary and can be determined empirically. The covariates which were most strongly associated with the severity of disease are important in experimental studies involving outbred animals with variable background.

    S GOWTAGE-SEQUEIRA, A PATERSON, K LYASHCHENKO, S LESELLIER, M CHAMBERS (2009)Evaluation of the CervidTB STAT-PAK for the Detection of Mycobacterium bovis Infection in Wild Deer in Great Britain, In: CLINICAL AND VACCINE IMMUNOLOGY16pp. 1449-1452
    FJ Salguero, S Lesellier, A Nunez, L Corner, T Crawshaw, M Chambers (2010)INTRAMUSCULAR BCG VACCINATION REDUCES SIGNIFICANTLY THE PATHOLOGY INDUCED BY MYCOBACTERIUM BOVIS IN BADGERS (MELES MELES), In: Journal of Comparative Pathology143pp. 347-347
    K LYASHCHENKO, R GREENWALD, J ESFANDIARI, M CHAMBERS, J VICENTE, C GORTAZAR, N SANTOS, M CORREIA-NEVES, B BUDDLE, R JACKSON, D O'BRIEN, S SCHMITT, M PALMER, R DELAHAY, W WATERS (2008)Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife, In: VETERINARY MICROBIOLOGY132pp. 283-292
    S LESELLIER, L CORNER, E COSTELLO, K LYASHCHENKO, R GREENWALD, J ESFANDIARI, M SINGH, R HEWINSONE, M CHAMBERS, E GORMLEY (2009)Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis, In: VACCINE27pp. 402-409
    S CLARK, M CROSS, A SMITH, P COURT, J VIPOND, A NADIAN, R HEWINSON, H BATCHELOR, Y PERRIE, A WILLIAMS, F ALDWELL, M CHAMBERS (2008)Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guerin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M-bovis, In: VACCINE26pp. 5791-5797
    FJ Salguero, A Richard, J Gough, A Long, U Weyer, WA Cooley, MA Chambers, S Lesellier (2010)Pelioid Hepatocellular Carcinoma in an Adult Eurasian Badger (Meles meles), In: Journal of Comparative Pathology142pp. 208-212
    A mass was identified within the left lateral lobe of the liver of a 10-year-old Eurasian badger (Meles meles). The mass was Friable and multilobulated, with blood-filled spaces between the lobules. Microscopically, the lesion consisted of sheets and trabeculae of neoplastic hepatocytes often forming cystic spaces containing erythrocytes, fibrin and necrotic debris. The histological appearance was consistent with hepatocellular carcinoma (HCC). Immunohistochemically, the neoplastic cells expressed cytokeratin 18 but riot von Willebrand factor. Multiple intranuclear (amphophilic or acidophilic) inclusion bodies were observed in hepatocytes at the junction between the tumour and normal hepatic tissue. HCCs have also been reported in other domestic and wild animals. As hepadnavirus infection has been associated with HCC in woodchucks, further histochemical and transmission electron microscopical Studies were performed; however, these demonstrated that the inclusions consisted of lipid droplets and not viral particles. To our knowledge, this is the first report of a naturally occurring HCC in a Eurasian badger. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
    M CHAMBERS, B MARSHALL, A WANGOO, A BUNE, H COOK, R SHAW, D YOUNG (1997)Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guerin, In: JOURNAL OF IMMUNOLOGY158pp. 1742-1748
    M CHAMBERS, S STACEY, J ARRAND, M STANLEY (1994)DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO HUMAN PAPILLOMAVIRUS TYPE-16 E6 PROTEIN IN A MOUSE MODEL, In: JOURNAL OF GENERAL VIROLOGY75pp. 165-169
    M CHAMBERS, B MARSHALL, A BUNE, S LADVA, T COOK, R SHAW, D YOUNG (1996)Different primary immune responses to BCG in a mouse model: Does the macrophage distinguish between viable and killed BCG?, In: JOURNAL OF PATHOLOGY179pp. A38-A38
    MA Chambers, F Rogers, RJ Delahay, S Lesellier, R Ashford, D Dalley, S Gowtage, D Dave, S Palmer, J Brewer, T Crawshaw, R Clifton-Hadley, S Carter, C Cheeseman, C Hanks, A Murray, K Palphramand, S Pietravalle, GC Smith, A Tomlinson, NJ Walker, GJ Wilson, LAL Corner, SP Rushton, MDF Shirley, G Gettinby, RA McDonald, RG Hewinson (2011)Bacillus Calmette-Guerin vaccination reduces the severity and progression of tuberculosis in badgers, In: Proceedings of the Royal Society B-Biological Sciences278pp. 1913-1920
    AJ Tomlinson, MA Chambers, SP Carter, GJ Wilson, GC Smith, RA McDonald, RJ Delahay (2013)Heterogeneity in the risk of Mycobacterium bovis infection in European badger (Meles meles) cubs, In: Epidemiology and Infection141pp. 1458-1466
    H KNOBLOCH, C TURNER, A SPOONER, M CHAMBERS (2009)Methodological variation in headspace analysis of liquid samples using electronic nose, In: SENSORS AND ACTUATORS B-CHEMICAL139pp. 353-360
    S Lesellier, S Palmer, S Gowtage-Sequiera, R Ashford, D Dalley, D Dave, U Weyer, FJ Salguero, A Nunez, T Crawshaw, LAL Corner, RG Hewinson, MA Chambers (2011)Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG, In: Vaccine29pp. 3782-3790
    A Robertson, RJ Delahay, RA McDonald, PA Aylett, R Henderson, S Gowtage, Mark Chambers, SP Carter (2016)Behaviour of European badgers and non-target species towards candidate baits for oral delivery of a tuberculosis vaccine, In: Preventive Veterinary Medicine135pp. 95-101 Elsevier
    In the UK and the Republic of Ireland, the European badger (Meles meles) is a maintenance host for Mycobacterium bovis, and may transmit the infection to cattle causing bovine tuberculosis (TB). Vaccination of badgers using an injectable Bacillus Calmette-Guerin (BCG) vaccine is undertaken in some areas of the UK with the intention of interrupting this transmission, and vaccination research is underway in Ireland. An oral badger TB vaccine is also under development. We investigated the behaviour of badgers and non-target wildlife species towards three candidate baits being considered for delivering BCG to badgers orally. Bait preference was investigated by recording removal rates of baits and through the use of video surveillance at 16 badger setts. We found high variation in rates of bait removal by badgers among setts but no significant differences in removal rates among bait types or in preference behaviour from video footage. Variation in bait removal among setts correlated with the number of nights on which badgers were seen at the sett, with most baits being removed where badgers were seen on >50% of nights during the ten-day study period. Relatively few baits were removed at setts with low levels of recorded badger activity. Monitoring badger activity prior to bait deployment may therefore be useful in increasing bait uptake and vaccine coverage. Bait removal by badgers increased over the ten-day study period, suggesting initial neophobic behaviour at some setts and that a period of ‘pre-feeding’ may be required prior to vaccine deployment. Our results indicate that all three candidate baits are attractive to badgers. Removal of baits by non-target wildlife species was generally low, but varied among bait types, with smaller baits in packaging less likely to be removed. Enclosing baits in packaging is likely to deter non-target species, although in some cases non-target species did remove up to 13% of packaged baits.
    A Balseiro, P González-Quirós, O Rodríguez, M Francisca Copano, I Merediz, L de Juan, MA Chambers, RJ Delahay, N Marreros, LJ Royo, J Bezos, JM Prieto, C Gortázar (2013)Spatial relationships between Eurasian badgers (Meles meles) and cattle infected with Mycobacterium bovis in Northern Spain, In: Vet J
    Recent studies suggest that badgers may be a potential reservoir of Mycobacterium bovis infection for cattle in Northern Spain. The objective of this study was to investigate potential epidemiological links between cattle and badgers. Culture and molecular typing data were available for cattle culled during the national tuberculosis (TB) eradication campaigns between 2008 and 2012, as well as from 171 necropsied badgers and 60 live animals trapped and examined over the same time period. Mycobacterium tuberculosis complex strains were isolated from pooled tissues of 14 (8.2%) necropsied badgers, of which 11 were identified as M. bovis: six different spoligotypes of M. bovis were subsequently identified. In two geographical locations where these isolates were shared between cattle and badgers, infected cattle herds and badgers lived in close contact. Although it remains unclear if badgers are a maintenance or spill-over host of M. bovis in this setting, it would appear prudent to have precautionary measures in place to reduce contact between cattle and badgers.
    M STANLEY, M CHAMBERS (1993)A DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO HUMAN PAPILLOMAVIRUS TYPE-16 (HPV16) PROTEINS, In: JOURNAL OF CELLULAR BIOCHEMISTRYpp. 112-112
    IY Saleem, M Vordermeier, MA Chambers, AGA Coombes (2000)Improving the sensitivity of polypeptide-based diagnostic assays, In: Journal of Pharmacy and Pharmacology52(9 SUPP)pp. 33-?
    D DALLEY, P HOGARTH, S HUGHES, R HEWINSON, M CHAMBERS (2004)Cloning and sequencing of badger (Meles meles) interferon gamma and its detection in badger lymphocytes, In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY101pp. 19-30
    M Stanley, N Coleman, M Chambers (1994)The host response to lesions induced by human papillomavirus., In: Ciba Found Symp187pp. 21-32
    Human papillomaviruses (HPVs) are strictly intraepithelial pathogens: in the natural productive infection they induce benign epithelial proliferations of mucocutaneous surfaces, some of which may progress to malignancy. Benign HPV-induced lesions are chronic persistent growths; high levels of viral antigen are expressed in the apparent absence of a host immune response suggesting that these viruses have evolved efficient mechanisms of immune evasion. Cell-mediated responses are central in the pathogenesis of HPV and regression of both cutaneous and genital warts histologically resembles a delayed-type hypersensitivity response (DTH). The antigen(s) in the wart against which this response is initiated are not known but in an experimental murine model DTH responses to the E6 and E7 proteins of HPV-16 can be elicited when viral antigen is presented via the epithelial route. Priming with low levels of viral antigen in this model induces non-responsiveness and the loss of DTH. In HPV-associated cancers the E6/E7 genes are expressed and an antibody response to the proteins is found in at least 50% of cases indicating that these oncoproteins are potential targets for immunotherapy.
    D Gavier-Widén, M Chambers, C Gortázar, R Delahay, R Cromie, A Lindén (2012)Mycobacteria Infections, In: Infectious Diseases of Wild Mammals and Birds in Europepp. 265-292
    Roland T. Ashford, Paul Anderson, Laura Waring, Dipesh Dave, Freya Smith, Richard J. Delahay, Eamonn Gormley, Mark A. Chambers, Jason Sawyer, Sandrine Lesellier (2020)Evaluation of the Dual Path Platform (DPP) VetTB assay for the detection of Mycobacterium bovis infection in badgers, In: PREVENTIVE VETERINARY MEDICINE180105005 ELSEVIER SCIENCE BV
    Bovine tuberculosis (bTB), caused by Mycobacterium bovis, represents a major animal health issue. In the United Kingdom and the Republic of Ireland, European badgers (Meles meles) have been shown to act as a reservoir of M. bovis infection, hindering the eradication of bTB in livestock. The availability of suitable diagnostic assays, particularly those that may be applied in a “trap-side” setting, would facilitate the implementation of a wider range of disease control strategies. Here we evaluate the Dual Path Platform (DPP) VetTB assay, a lateral-flow type test for detecting antibodies to M. bovis antigens (MPB83 and ESAT-6/CFP-10). Both serum and whole blood were evaluated as diagnostic samples. Additionally, two methods were evaluated for interpretation of test results (qualitative interpretation by eye and quantitative measurement using an optical reader). The antibody response to MPB83 detected by the DPP VetTB assay increased significantly following experimental M. bovis infection of badgers, whilst the response to ESAT-6/CFP-10 showed no significant change. In sera from TB-free captive and naturally M. bovis infected wild badgers the MPB83 response exhibited a sensitivity of 55 % by eye and quantitative reader (95 % CI: 40–71 and 38–71, respectively), with slightly lower specificity when read by eye (93 % compared to 98 %; 95 % CI: 85–100 and 90–100, respectively). In whole blood, the DPP VetTB assay MPB83 response exhibited a sensitivity of 65 % (95 % CI: 50–80) when interpreted by eye and 53 % (95 % CI: 36–69) using quantitative values, whilst the specificity was 94 % and 98 % respectively (95 % CI: 88–100 and 90–100). Comparison with contemporaneous diagnostic test results from putatively naturally infected and TB-free badgers demonstrated varying levels of agreement. Using sera from naturally M. bovis infected and TB-free badgers, with post mortem confirmation of disease status, the DPP VetTB assay exhibited a sensitivity of 60 % (95 % CI: 41–77) when interpreted using quantitative values (specificity 95 %; 95 % CI: 76–100), and 67 % (95 % CI: 50–84) when read by eye (specificity 95 %; 95 % CI: 86–100). Further work is required to robustly characterize the DPP VetTB assay’s performance in a wider selection of samples, and in the practical and epidemiological contexts in which it may be applied.
    D Kiran, BK Podell, M Chambers, RJ Basaraba (2015)Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review, In: Seminars in Immunopathology Springer
    © 2015 The Author(s) Infection by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb) is a major cause of morbidity and mortality worldwide. Slow progress has been made in lessening the impact of tuberculosis (TB) on human health, especially in parts of the world where Mtb is endemic. Due to the complexity of TB disease, there is still an urgent need to improve diagnosis, prevention, and treatment strategies to control global spread of disease. Active research targeting avenues to prevent infection or transmission through vaccination, to diagnose asymptomatic carriers of Mtb, and to improve antimicrobial drug treatment responses is ongoing. However, this research is hampered by a relatively poor understanding of the pathogenesis of early infection and the factors that contribute to host susceptibility, protection, and the development of active disease. There is increasing interest in the development of adjunctive therapy that will aid the host in responding to Mtb infection appropriately thereby improving the effectiveness of current and future drug treatments. In this review, we summarize what is known about the host response to Mtb infection in humans and animal models and highlight potential therapeutic targets involved in TB granuloma formation and resolution. Strategies designed to shift the balance of TB granuloma formation toward protective rather than destructive processes are discussed based on our current knowledge. These therapeutic strategies are based on the assumption that granuloma formation, although thought to prevent the spread of the tubercle bacillus within and between individuals contributes to manifestations of active TB disease in human patients when left unchecked. This effect of granuloma formation favors the spread of infection and impairs antimicrobial drug treatment. By gaining a better understanding of the mechanisms by which Mtb infection contributes to irreversible tissue damage, down regulates protective immune responses, and delays tissue healing, new treatment strategies can be rationally designed. Granuloma-targeted therapy is advantageous because it allows for the repurpose of existing drugs used to treat other communicable and non-communicable diseases as adjunctive therapies combined with existing and future anti-TB drugs. Thus, the development of adjunctive, granuloma-targeted therapy, like other host-directed therapies, may benefit from the availability of approved drugs to aid in treatment and prevention of TB. In this review, we have attempted to summarize the results of published studies in the context of new innovative approaches to host-directed therapy that need to be more thoroughly explored in pre-clinical animal studies and in human clinical trials.
    SN Buzdugan, MA Chambers, RJ Delahay, JA Drewe (2016)Diagnosis of tuberculosis in groups of badgers: an exploration of the impact of trapping efficiency, infection prevalence and the use of multiple tests., In: Epidemiology and Infection144(8)pp. 1717-1727
    Accurate detection of infection with Mycobacterium bovis in live badgers would enable targeted tuberculosis control. Practical challenges in sampling wild badger populations mean that diagnosis of infection at the group (rather than the individual) level is attractive. We modelled data spanning 7 years containing over 2000 sampling events from a population of wild badgers in southwest England to quantify the ability to correctly identify the infection status of badgers at the group level. We explored the effects of variations in: (1) trapping efficiency; (2) prevalence of M. bovis; (3) using three diagnostic tests singly and in combination with one another; and (4) the number of badgers required to test positive in order to classify groups as infected. No single test was able to reliably identify infected badger groups if 80% sensitive, at least 94% specific, and able to be performed rapidly in the field.
    J Blancou, M Artois, E Gilot-Fromont, V Kaden, S Rossi, GC Smith, MR Hutchings, MA Chambers, S Houghton, RJ Delahay (2009)Options for the control of disease 1: Targeting the infectious or parasitic agent, In: Management of Disease in Wild Mammalspp. 97-120
    There are three basic approaches to managing diseases: directly reduce the reproductive rate of the pathogen, reduce host (or infected host) density, or manipulate the environment to reduce contact between diseased and susceptible animals. In this chapter we will look at the first of these approaches. Since disease transmission results from direct or indirect contact between infectious and susceptible individuals, there are two ways to target an infectious agent: either limit the number of susceptible individuals by vaccinating them, or treat infected individuals in order to reduce the duration or intensity of the infectious period and the number of infectious individuals present at any given time. The overall aim of this chapter is to consider the conditions under which vaccination and treatment may make a valuable contribution to the control of infectious diseases in wild mammal populations. Both field research and mathematical modelling approaches have been used to address this question. For vaccination, early mathematical models of infectious disease dynamics suggested a simple answer: vaccination is useful as soon as the rate of control ensures that a sufficient proportion of the population is immune for a sufficient period of time (Bailey 1957). At the individual level, this herd immunity means that any given infectious individual has a low probability of encountering a susceptible animal. If the disease is introduced into a vaccinated population, the mean number of secondary infections caused by each infected case will be lower than unity, thus preventing further outbreaks from occurring (R <: see Chapter 3). However, this generalised scenario may be considered overly simplistic, as the practicalities of vaccination campaigns often complicate matters. For example, modelling studies often include assumptions about perfect vaccine efficacy, and the efficiency of delivering the vaccine to a population that may or may not reflect the situation in the field. © Springer 2009.
    D DALLEY, D DAVE, S LESELLIER, S PALMER, T CRAWSHAW, R HEWINSON, M CHAMBERS (2008)Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles), In: TUBERCULOSIS88pp. 235-243
    M ZHU, M GOUGH, P PATEL, R BANKS, M CHAMBERS, P SELBY, A JACKSON (1996)Engineering mycobacteria to express IL-15, In: IMMUNOLOGY89pp. B15-B15
    AJ Tomlinson, MA Chambers, GJ Wilson, RA McDonald, RJ Delahay (2013)Sex-Related Heterogeneity in the Life-History Correlates of Mycobacterium bovis Infection in European Badgers (Meles meles), In: Transbound Emerg Dis60 Suppp. 37-45
    Heterogeneity in the progression of disease amongst individual wild animals may impact on both pathogen and host dynamics at the population level, through differential effects on transmission, mortality and reproductive output. The role of the European badger (Meles meles) as a reservoir host for Mycobacterium bovis infection in the UK and Ireland has been the focus of intense research for many years. Here, we investigate life-history correlates of infection in a high-density undisturbed badger population naturally infected with M. bovis. We found no evidence of a significant impact of M. bovis infection on female reproductive activity or success, with evidence of reproduction continuing successfully for several years in the face of M. bovis excretion. We also found evidence to support the hypothesis that female badgers are more resilient to established M. bovis infection than male badgers, with longer survival times following the detection of bacterial excretion. We discuss the importance of infectious breeding females in the persistence of M. bovis in badger populations, and how our findings in male badgers are consistent with testosterone-induced immunosuppression. In addition, we found significant weight loss in badgers with evidence of disseminated infection, based on the culture of M. bovis from body systems other than the respiratory tract. For females, there was a gradual loss of weight as infection progressed, whereas males only experienced substantial weight loss when infection had progressed to the point of dissemination. We discuss how these differences may be explained in terms of resource allocation and physiological trade-offs.
    P HOGARTH, K JAHANS, R HECKER, R HEWINSON, M CHAMBERS (2003)Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs, In: VACCINE21pp. 977-982
    MA Chambers, SP Carter, GJ Wilson, G Jones, E Brown, RG Hewinson, M Vordermeier (2014)Vaccination against tuberculosis in badgers and cattle: an overview of the challenges, developments and current research priorities in Great Britain, In: VETERINARY RECORD175(4)pp. 90-96 BMJ PUBLISHING GROUP
    R GREENWALD, J ESFANDIARI, S LESELLIER, R HOUGHTON, J POLLOCK, C AAGAARD, P ANDERSEN, R HEWINSON, M CHAMBERS, K LYASHCHENKO (2003)Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats, In: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE46pp. 197-203
    M CHAMBERS, K JAHANS, A WHELAN, C HUGHES, R SAYERS, A PERKINS, R HEWINSON (2002)Simple objective measurement of the cutaneous delayed-type hypersensitivity reaction to tuberculin using spectrophotometry, In: SKIN RESEARCH AND TECHNOLOGY8pp. 89-93
    S CLARK, M CROSS, A NADIAN, J VIPOND, P COURT, A WILLIAMS, R HEWINSON, F ALDWELL, M CHAMBERS (2008)Oral vaccination of guinea pigs with a mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis, In: INFECTION AND IMMUNITY76pp. 3771-3776
    Imran Saleem, Allan G. A. Coombes, Mark A. Chambers (2019)In Vitro Evaluation of Eudragit Matrices for Oral Delivery of BCG Vaccine to Animals, In: Pharmaceutics11(6) MDPI
    Bacillus Calmette–Guérin (BCG) vaccine is the only licensed vaccine against tuberculosis (TB) in humans and animals. It is most commonly administered parenterally, but oral delivery is highly advantageous for the immunisation of cattle and wildlife hosts of TB in particular. Since BCG is susceptible to inactivation in the gut, vaccine formulations were prepared from suspensions of Eudragit L100 copolymer powder and BCG in phosphate-buffered saline (PBS), containing Tween® 80, with and without the addition of mannitol or trehalose. Samples were frozen at -20 °C, freeze-dried and the lyophilised powders were compressed to produce BCG–Eudragit matrices. Production of the dried powders resulted in a reduction in BCG viability. Substantial losses in viability occurred at the initial formulation stage and at the stage of powder compaction. Data indicated that the Eudragit matrix protected BCG against simulated gastric fluid (SGF). The matrices remained intact in SGF and dissolved completely in simulated intestinal fluid (SIF) within three hours. The inclusion of mannitol or trehalose in the matrix provided additional protection to BCG during freeze-drying. Control needs to be exercised over BCG aggregation, freeze-drying and powder compaction conditions to minimise physical damage of the bacterial cell wall and maximise the viability of oral BCG vaccines prepared by dry powder compaction.
    M CHAMBERS, D WRIGHT, J BRISKER, A WILLIAMS, G HATCH, D GAVIER-WIDEN, G HALL, P MARSH, R HEWINSON (2004)A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome (TM)) protects guinea pigs from lethal tuberculosis, In: VACCINE22pp. 1063-1071
    D KING, N MUTUKWA, S LESELLIER, C CHEESEMAN, M CHAMBERS, M BANKS (2004)Detection of mustelid herpesvirus-1 infected European badgers (Meles meles) in the British Isles, In: JOURNAL OF WILDLIFE DISEASES40pp. 99-102
    A SOUTHEY, D SLEEMAN, K LLOYD, D DALLEY, M CHAMBERS, R HEWINSON, E GORMLEY (2001)Immunological responses of Eurasian badgers (Meles meles) vaccinated with Mycobacterium bovis BCG (bacillus calmette guerin), In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY79pp. 197-207
    M CHAMBERS, W PRESSLING, C CHEESEMAN, R CLIFTON-HADLEY, R HEWINSON (2002)Value of existing serological tests for identifying badgers that shed Mycobacterium bovis, In: VETERINARY MICROBIOLOGY86pp. 183-189
    S KAMPFER, D DALLEY, R HEWINSON, M CHAMBERS, M SINGH (2003)Multi-antigen ELISA for enhanced diagnosis of tuberculosis in badgers, In: VETERINARY RECORD153pp. 403-404
    S LESELLIER, S PALMER, D DALLEY, D DAVE, L JOHNSON, R HEWINSON, M CHAMBERS (2006)The safety and immunogenicity of Bacillus Calmette-Guerin (BCG) vaccine in European badgers (Meles meles), In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY112pp. 24-37
    The infection of both captive and free-ranging wildlife species with pathogenic mycobacteria (including Mycobacterium tuberculosis) poses a zoonotic risk and continues to cause challenges for the livestock industry, zoos and governments around the world. Central to the management and control of tuberculosis is timely and accurate diagnosis. In many cases, bacterial culture is insufficiently sensitive and confirmation of TB post-mortem is neither feasible nor desirable. In this context, there is still considerable research interest in, and need for, immunological methods for diagnosis. Reviews on this topic were published in 2005 and 2009, but since then veterinarians and other researchers have continued to evaluate immunodiagnostic approaches to TB. These include serological tests such as lateral-flow devices, and enzyme-linked immunosorbent assay (ELISA) and those based on evaluation of cell-mediated immunity, such as the tuberculin skin test and interferon-gamma release assay (IGRA). Since 2009, the range of publications on this topic has been extended to a number of new species, including South American camelids, black rhinoceros, lions and non-human primates. Therefore, it seemed appropriate to review the literature in the 3 years since 2009 and provide an overview of progress.
    H Knobloch, W Schroedl, C Turner, M Chambers, P Reinhold (2010)Electronic nose responses and acute phase proteins correlate in blood using a bovine model of respiratory infection, In: SENSORS AND ACTUATORS B-CHEMICAL144(1)pp. 81-87 ELSEVIER SCIENCE SA
    B BUDDLE, M SKINNER, M CHAMBERS (2000)Immunological approaches to the control of tuberculosis in wildlife reservoirs, In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY74pp. 1-16
    M CHAMBERS, D GAVIER-WIDEN, R HEWINSON (2006)Histopathogenesis of experimental Mycobacterium bovis infection in mice, In: RESEARCH IN VETERINARY SCIENCE80pp. 62-70
    B MARSHALL, M CHAMBERS (1998)Central nervous system tuberculosis - The paradox of the host immune response, In: JOURNAL OF INFECTION36pp. 3-4
    H VORDERMEIER, M CHAMBERS, B BUDDLE, J POLLOCK, R HEWINSON (2006)Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle, In: VETERINARY JOURNAL171pp. 229-244
    C Turner, H Knobloch, J Richards, P Richards, TTF Mottram, DJ Marlin, MA Chambers (2012)Development of a device for sampling cattle breath, In: J Biosystem Engineering112pp. 75-81
    RJ Delahay, N Walker, GS Smith, D Wilkinson, RS Clifton-Hadley, CL Cheeseman, AJ Tomlinson, MA Chambers (2013)Long-term temporal trends and estimated transmission rates for Mycobacterium bovis infection in an undisturbed high-density badger (Meles meles) population, In: Epidemiology and Infection141pp. 1445-1456
    D DALLEY, M CHAMBERS, P COCKLE, W PRESSLING, D GAVIER-WIDEN, R HEWINSON (1999)A lymphocyte transformation assay for the detection of Mycobacterium bovis infection in the Eurasian Badger (Meles meles), In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY70pp. 85-94
    M CHAMBERS, H VORDERMEIER, A WHELAN, N COMMANDER, R TASCON, D LOWRIE, R HEWINSON (2000)Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB8330pp. S283-S287
    E WOOFF, S MICHELL, S GORDON, M CHAMBERS, S BARDAROV, W JACOBS, R HEWINSON, P WHEELER (2002)Functional genomics reveals the sole sulphate transporter of the Mycobacterium tuberculosis complex and its relevance to the acquisition of sulphur in vivo, In: MOLECULAR MICROBIOLOGY43pp. 653-663
    Anna Stedman, Mark A. Chambers, Jorge Gutierrez-Merino (2019)Secretion and functional expression of Mycobacterium bovis antigens MPB70 and MPB83 in lactic acid bacteria, In: TUBERCULOSIS117pp. 24-30 Elsevier
    The aim of this study was to determine the reliability of lactic acid bacteria (LAB) as heterologous hosts for the expression of MPB70 and MPB83, two Mycobacterium bovis antigens that possess diagnostics and immunogenic properties, respectively. We therefore generated recombinant cells of Lactococcus lactis and Lactobacillus plantarum that carried hybrid genes encoding MPB70 and MPB83 fused to signal peptides that are specifically recognized by LAB. Only L. lactis was able to secrete MPB70 using the L. lactis signal peptide Usp45, and to produce MPB83 as an immunogenic membrane protein following its expression with the signal peptide of the L. plantarum lipoprotein prsA. Inactivated cells of MPB83-expressing L. lactis cultures enhanced NF-κB activation in macrophages. Our results show that L. lactis is a reliable host for the secretion and functional expression of antigens that are naturally produced by M. bovis, the causative agent of bovine tuberculosis (bTB). This represents the first step on a long process to establishing whether recombinant LAB could serve as a food-grade platform for potential diagnostic tools and/or vaccine interventions for use against bTB, a chronic disease that primarily affects cattle but also humans and a wide range of domestic and wild animals.
    M CHAMBERS, D GAVIER-WIDEN, P STANLEY, R HEWINSON (2000)Biochemical and haematological parameters associated with tuberculosis in European badgers, In: VETERINARY RECORD146pp. 734-735
    RM Jones, R Ashford, J Cork, S Palmer, E Wood, P Spyvee, S Parks, A Bennett, J Brewer, R Delahay, M Chambers, J Sawyer (2013)Evaluation of a method to detect Mycobacterium bovis in air samples from infected Eurasian badgers (Meles meles) and their setts, In: Letters in Applied Microbiology56pp. 361-365
    S LESELLIER, L CORNER, E COSTELLO, P SLEEMAN, K LYASHCHENKO, R GREENWALD, J ESFANDIARI, R HEWINSON, M CHAMBERS, E GORMLEY (2009)Immunological responses following experimental endobronchial infection of badgers (Metes meles) with different doses of Mycobacterium bovis, In: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY127pp. 174-180
    Rachel E. Butler, Alex A. Smith, Tom A. Mendum, Aneesh Chandran, Huihai Wu, Louise Lefrançois, Mark Chambers, Thierry Soldati, Graham R. Stewart (2020)Mycobacterium bovis uses the ESX-1 Type VII secretion system to escape predation by the soil-dwelling amoeba Dictyostelium discoideum, In: The ISME Journal Springer Nature
    Mycobacterium bovis is the causative agent of bovine tuberculosis and the predominant cause of zoonotic tuberculosis in people. Bovine tuberculosis occurs in farmed cattle but also in a variety of wild animals, which form a reservoir of infection. Although direct transmission of tuberculosis occurs between mammals, the low frequency of contact between different host species and abundant shedding of bacilli by infected animals suggests an infectious route via environmental contamination. Other intracellular pathogens that transmit via the environment deploy strategies to survive or exploit predation by environmental amoebae. To explore if M. bovis has this capability, we investigated its interactions with the soil and dung-dwelling amoeba, Dictyostelium discoideum. We demonstrated that M. bovis evades phagocytosis and destruction by D. discoideum and actively transits through the amoeba using the ESX-1 Type VII Secretion System as part of a programme of mechanisms, many of which have been co-opted as virulence factors in the mammalian host. This capacity of M. bovis to utilise an environmental stage between mammalian hosts may enhance its transmissibility. In addition, our data provide molecular evidence to support an evolutionary role for amoebae as training grounds for the pathogenic M. tuberculosis complex.
    MA Chambers, F Aldwell, GA Williams, S Palmer, S Gowtage, R Ashford, D Dalley, D Davé, U Weyer, Francisco Salguero Bodes, A Nunez, A Nadian, T Crawshaw, LAL Corner, S Lesellier (2017)The effect of oral vaccination with Mycobacterium bovis BCG on the development of tuberculosis in captive European badgers (Meles meles), In: Frontiers in cellular and infection microbiology7(6) Frontiers Media
    The European badger (Meles meles) is a reservoir host of Mycobacterium bovis and responsible for a proportion of the tuberculosis (TB) cases seen in cattle in the United Kingdom and Republic of Ireland. An injectable preparation of the bacillus Calmette-Guérin (BCG) vaccine is licensed for use in badgers in the UK and its use forms part of the bovine TB eradication plans of England and Wales. However, there are practical limitations to the widespread application of an injectable vaccine for badgers and a research priority is the development of an oral vaccine deliverable to badgers in bait. Previous studies reported the successful vaccination of badgers with oral preparations of 108 colony forming units (CFU) of both Pasteur and Danish strains of BCG contained within a lipid matrix composed of triglycerides of fatty acids. Protection against TB in these studies was expressed as a reduction in the number and apparent progression of visible lesions, and reductions in the bacterial load and dissemination of infection. To reduce the cost of an oral vaccine and reduce the potential for environmental contamination with BCG, it is necessary to define the minimal efficacious dose of oral BCG for badgers. The objectives of the two studies reported here were to compare the efficacy of BCG Danish strain in a lipid matrix with unformulated BCG given orally, and to evaluate the efficacy of BCG Danish in a lipid matrix at a ten-fold lower dose than previously evaluated in badgers. In the first study, both BCG unformulated and in a lipid matrix reduced the number and apparent progression of visible lesions and the dissemination of infection from the lung. In the second study, vaccination with BCG in the lipid matrix at a ten-fold lower dose produced a similar outcome, but with greater intra-group variability than seen with the higher dose in the first study. Further research is needed before we are able to recommend a final dose of BCG for oral vaccination of badgers against TB or to know whether oral vaccination of wild badgers with BCG will significantly reduce transmission of the disease.
    BG Marshall, MA Chambers, A Wangoo, HT Cook, DB Young, RJ Shaw (1996)Understanding the different inflammatory responses to live and dead BCG: A prerequisite for improved vaccine design, In: Thorax51(SUPPL.)
    Specific antituberculous resistance appears to be induced following inoculation of live but not dead BCG. This dependence on BCG viability may explain the diverse responses in terms of protective immunity in clinical trials of BCG conducted worldwide over the last thirty years. In order to dissect out simple parameters which may differentiate a protective from a non-protective response, we have developed a murine in vivo model of experimental BCG infection to study the immune response in draining lymph nodes following footpad inoculation with either live or killed BCG preparations. In this model, live but not heat-killed BCG efficiently migrate to the draining lymph nodes and stimulate the early accumulation of mononuclear cells. In addition, live and heat-killed BCG stimulate different responses in terms of the level of expression of interferon-gamma, inducible nitric oxide (iNOS), as well as macrophage and dendritic cell markers in the draining lymph nodes. This divergent in vivo response was reproduced in vitro when pure macrophage cultures were infected with BCG and responded differently to live and dead preparations, producing significant levels of TNF and reactive nitrogen intermediates only when infected with live BCG. Taken together, these observations suggest that the differences encountered in vivo may be related to the ability of live BCG to migrate to local lymph node, where they cause the accumulation of cells expressing protective cytokines and therefore inducing an efficient immune response. These findings may have important implications for the design of new anti-tuberculosis vaccines.
    MA Chambers, WA Pressling, CL Cheeseman, RS Clifton-Hadley, RG Hewinson (2005)Value of existing serological tests for identifying badgers that shed Mycobacterium bovis, In: CATTLE PRACTICE13pp. 333-336 BRITISH CATTLE VETERINARY ASSOC
    H Knobloch, C Turner, M Chambers, P Reinhold (2009)Serum Headspace Analysis With An Electronic Nose And Comparison With Clinical Signs Following Experimental Infection Of Cattle With Mannheimia Haemolytica, In: OLFACTION AND ELECTRONIC NOSE, PROCEEDINGS1137pp. 439-442
    S LESELLIER, D DALLEY, D DAVE, S PALMER, G HEWINSON, M CHAMBERS (2005)Evaluation of BCG vaccine safety and immunogenicity in badgers, In: IMMUNOLOGY116pp. 109-109
    M Chambers, SP Graham, RM La Ragione (2016)Challenges in Veterinary Vaccine Development and Immunization, In: Vaccine Design2 Vacc(1)pp. 3-35 Springer
    M HAILE, B HAMASUR, T JAXMAR, D GAVIER-WIDEN, M CHAMBERS, B SANCHEZ, U SCHRODER, G KALLENIUS, S SVENSON, A PAWLOWSKI (2005)Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice, In: TUBERCULOSIS85pp. 107-114
    A Robertson, A Robertson, MA Chambers, MA Chambers, RJ Delahay, RA McDonald, KL Palphramand, F Rogers, SP Carter (2015)Exposure of nontarget wildlife to candidate TB vaccine baits deployed for European badgers, In: European Journal of Wildlife Research61(2)pp. 263-269
    © 2015, Springer-Verlag Berlin Heidelberg. In the UK and Republic of Ireland, the European badger Meles meles is considered a maintenance host for bTB and is involved in transmission of infection to cattle. A badger vaccine delivered in an oral bait is currently under development as part of an ongoing effort to reduce levels of disease in the badger population. An oral vaccine would likely be deployed in close vicinity to badger burrows (setts), such that bait will most likely be taken by the target species. However, a range of nontarget species may also occur close to badger setts, and some may potentially interfere with or consume baits. In this study, we used surveillance cameras to record the presence of nontarget species at 16 badger setts involved in a bait deployment study in southwest England. We recorded significant levels of nontarget species activity close to badger setts. The most commonly observed species were small rodents, which were observed at all setts, and in some cases accounted for >90 % of nontarget species observations. A total of 11 other nontarget species were also observed, indicating that a broad range of species may potentially come into contact with vaccine baits deployed at badger setts. Although the majority of these species were not observed interacting directly with baits, small rodents and squirrels were observed eating baits in a number of instances. In addition, monitoring of bait disappearance at 24 setts indicated that small rodents may take >30 % of bait deployed at some setts. The implications for the deployment of an oral vaccine for badgers are discussed.
    H Knobloch, H Koehler, N Commander, P Reinhold, C Turner, M Chambers (2009)Volatile Organic Compound (VOC) Analysis For Disease Detection: Proof Of Principle For Field Studies Detecting Paratuberculosis And Brucellosis, In: OLFACTION AND ELECTRONIC NOSE, PROCEEDINGS1137pp. 195-197
    R FEND, R GEDDES, S LESELLIER, H VORDERMEIER, L CORNER, E GORMLEY, E COSTELLO, R HEWINSON, D MARLIN, A WOODMAN, M CHAMBERS (2005)Use of an electronic nose to diagnose Mycobacterium bovis infection in badgers and cattle, In: JOURNAL OF CLINICAL MICROBIOLOGY43pp. 1745-1751
    Bovine tuberculosis is one of the biggest challenges facing cattle farming in Great Britain. European badgers (Meles meles) are a reservoir host for the causal agent, Mycobacterium bovis. There have been significant recent advances in diagnostic testing for tuberculosis in humans, cattle and badgers, with the development of species-specific assays for interferon-γ (IFN-γ), an important cytokine in tuberculous infections. Using data collected from longitudinal studies of naturally infected wild badgers, we report that the magnitude of the IFN-γ response to M. bovis antigens at the disclosing test event was positively correlated with subsequent progression of disease to a seropositive or excreting state. In addition, we show that the magnitude of the IFN-γ response, despite fluctuation, declined with time after the disclosing event for all badgers, but remained significantly higher in those animals with evidence of disease progression. We discuss how our findings may be related to the immunopathogenesis of natural M. bovis infection in badgers.
    M Chambers, G Dougan, J Newman, F Brown, J Crowther, AP Mould, MJ Humphries, MJ Francis, B Clarke, AL Brown, D Rowlands (1996)Erratum: Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions (Journal of Virology (1994) 70:6 (4045-4052)), In: Journal of Virology70(8)pp. 5740-?
    P CANFIELD, M DAY, D GAVIER-WIDEN, R HEWINSON, M CHAMBERS (2002)Immunohistochemical characterization of tuberculous and non-tuberculous lesions in naturally infected European badgers (Meles meles), In: JOURNAL OF COMPARATIVE PATHOLOGY126pp. 254-264
    M Chambers, G Dougan, J Newman, F Brown, J Crowther, AP Mould, MJ Humphries, MJ Francis, B Clarke, AL Brown, D Rowlands (1996)Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions, In: JOURNAL OF VIROLOGY70(6)pp. 4045-4052 AMER SOC MICROBIOLOGY
    H Knobloch, C Turner, A Spooner, M Chambers (2009)Methodological Variability Using Electronic Nose Technology For Headspace Analysis, In: OLFACTION AND ELECTRONIC NOSE, PROCEEDINGS1137pp. 327-330
    T XUE, E STAVROPOULOS, M YANG, S RAGNO, M VORDERMEIER, M CHAMBERS, G HEWINSON, D LOWRIE, M COLSTON, R TASCON (2004)RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection, In: INFECTION AND IMMUNITY72pp. 6324-6329
    Anna Stedman, Carlos Maluquer de Motes, Sandrine Lesellier, Deanna Dalley, Mark Chambers, Jorge Gutierrez-Merino (2018)Lactic acid Bacteria isolated from European badgers (Meles meles) reduce the viability and survival of Bacillus Calmette-Guerin (BCG) vaccine and influence the immune response to BCG in a human macrophage model, In: BMC Microbiology18(74) BioMed Central
    Background:

    Bovine tuberculosis (bTB) caused by Mycobacterium bovis is the most serious endemic disease affecting livestock in the UK. The European badger (Meles meles) is the most important wildlife reservoir of bTB transmission to cattle, making eradication particularly difficult. In this respect, oral vaccination with the attenuated M. bovis vaccine Bacillus Calmette-Guerin (BCG) has been suggested as a wide-scale intervention to reduce bTB infection in badgers. However, experimental studies show variable protection. Among the possibilities for this variation is that the resident gut bacteria may influence the success of oral vaccination in badgers; either through competitive exclusion and/or inhibition, or via effects on the host immune system. In order to explore this possibility, we have tested whether typical gut commensals such as Lactic Acid Bacteria (LAB) have the capacity to impact on the viability and survival rate of BCG and to modulate the immune response to BCG using an in vitromodel.

    Results:

    Twelve LAB isolated from badger faeces displayed inhibitory activity to BCG that was species-dependent. Weissella had a bacteriostatic effect, whereas isolates of enterococci, lactobacilli and pediococci had a more bactericidal activity. Furthermore, BCG-induced activation of the pro-inflammatory transcription factor NF-κB in human THP-1 macrophages was modulated by LAB in a strain-dependent manner. Most pediococci enhanced NF-κB activation but one strain had the opposite effect. Interestingly, isolates of enterococci, lactobacilli and weissella had different effects as immunomodulators of BCG-induced macrophage responses as some had no significant influence on NF-κB activation, but others increased it significantly.

    Conclusions:

    Our in vitro results show that LAB isolated from badgers exhibit significant inhibitory activity against BCG and influence the immune activation mediated by BCG in a human macrophage assay. These findings suggest that gut commensal bacteria could play a role in influencing the outcome of oral BCG vaccination. Inactivated cells of LAB, or LAB that are bacteriostatic but have a synergistic immunostimulatory effect with BCG, could be potential adjuvants to be used for oral vaccination in badgers. Further work is needed to take into account the complex nature of the gut microbiome, specific immunity of the badger and the in vivo context.

    LAL Corner, E Costello, D O'Meara, S Lesellier, FE Aldwell, M Singh, RG Hewinson, MA Chambers, E Gormley (2010)Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis, In: Vaccine28pp. 6265-6272
    SC Hill, AA Murphy, M Cotten, AL Palser, P Benson, S Lesellier, E Gormley, C Richomme, S Grierson, DN Bhuachalla, M Chambers, P Kellam, M-L Boschiroli, B Ehlers, MA Jarvis, OG Pybus (2015)Discovery of a polyomavirus in European badgers (Meles meles) and the evolution of host range in the family Polyomaviridae, In: Journal of General Virology96(6)pp. 1411-1422 Microbiology Society
    Polyomaviruses infect a diverse range of mammalian and avian hosts, and are associated with a variety of symptoms. However, it is unknown whether the viruses are found in all mammalian families and the evolutionary history of the polyomaviruses is still unclear. Here, we report the discovery of a novel polyomavirus in the European badger (Meles meles), which to our knowledge represents the first polyomavirus to be characterized in the family Mustelidae, and within a European carnivoran. Although the virus was discovered serendipitously in the supernatant of a cell culture inoculated with badger material, we subsequently confirmed its presence in wild badgers. The European badger polyomavirus was tentatively named Meles meles polyomavirus 1 (MmelPyV1). The genome is 5187 bp long and encodes proteins typical of polyomaviruses. Phylogenetic analyses including all known polyomavirus genomes consistently group MmelPyV1 with California sea lion polyomavirus 1 across all regions of the genome. Further evolutionary analyses revealed phylogenetic discordance amongst polyomavirus genome regions, possibly arising from evolutionary rate heterogeneity, and a complex association between polyomavirus phylogeny and host taxonomic groups.
    Diane Frances Lee, Francisco Javier Salguero, Duncan Grainger, Robert James Francis, Kirsty MacLellan-Gibson, Mark Andrew Chambers (2018)Isolation and characterisation of alveolar type II pneumocytes from adult bovine lung, In: Scientific Reports8(1) Nature Publishing Group
    Alveolar type II (ATII) cells play a key role as part of the distal lung epithelium, including roles in the innate immune response and as self-renewing progenitors to replace alveolar type I (ATI) cells during regeneration of the alveolar epithelium. Their secretion of surfactant protein helps to maintain homeostasis in the distal lung and exert protective, antimicrobial properties. Despite the cell’s crucial roles, they remain difficult to study, in part due to inefficient and expensive isolation methods, a propensity to differentiate into alveolar type I cells in culture and susceptibility to fibroblast overgrowth from primary isolations. Published methods of isolation often require specialist technology, negatively impacting the development of in vitro models of disease, including bovine tuberculosis (BTB), a serious re-emerging disease in both animals and humans worldwide. We present here a simple and cost effective method that may be utilised in the generation of bovine primary ATII cells. These exhibit an ATII phenotype in 2D and 3D culture in our studies and are conducive to further study of the role of ATII cells in bovine respiratory diseases.
    Kate Palphramand, Richard Delahay, Andy Robertson, Sonya Gowtage, Gareth A. Williams, Robbie A. McDonald, Mark Chambers, Stephen P. Carter (2017)Field evaluation of candidate baits for oral delivery of BCG vaccine to European badgers, Meles meles, In: VACCINE35(34)pp. 4402-4407 ELSEVIER SCI LTD
    The control of tuberculosis (TB) in cattle in the UK and Ireland is compromised by transmission of Mycobacterium bovis to cattle from the European badger (Meles meles), which acts as a wildlife reservoir. Vaccination of badgers could potentially contribute to TB control but the only licensed vaccine is injectable BadgerBCG which requires the live-capture of badgers. Current research is aimed at developing an oral TB vaccine (where vaccine is contained within bait) that is intended to be more cost-effective to deploy over large areas. In order to identify a lead product, candidate baits identified from captive badger studies were evaluated in three successive bait screening studies with wild badgers. A fourth field study, using the lead candidate bait and biomarkers, investigated the effectiveness of different carriers for their potential to deliver liquid payloads (vaccine surrogate). In each field study, bait disappearance was monitored daily for ten days and remote video surveillance was used to determine preference (i.e. the order in which baits were taken). In the carrier study, biomarkers were used to determine what proportion of subsequently trapped badgers had ingested the bait and the vaccine-carrier biomarker payload. Across all four studies, 79% (3397/4330) of baits were taken by badgers although the number varied significantly by badger social group and bait type. In all studies, bait disappearance increased over time, with 75–100% of baits being taken by day ten. In the carrier study, 75% (9/12) of trapped badgers tested positive for at least one of the biomarkers and the type of carrier did not influence bait attractiveness. Together with data from complementary laboratory and captive animal studies, this study identified a highly attractive and palatable bait (peanut-based paste bait; PT) and vaccine-carrier (hydrogenated peanut oil; HPO) combination with the potential to deliver a liquid vaccine to wild badgers.
    Thierry Boulinier, Stephen P. Carter, Andrew Robertson, Kate L. Palphramand, Mark A. Chambers, Robbie A. McDonald, Richard J. Delahay (2018)Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis, In: PLoS ONE13(11) Public Library of Science
    The deployment of baits containing vaccines or toxins has been used successfully in the management of wildlife populations, including for disease control. Optimisation of deployment strategies seeks to maximise uptake by the targeted population whilst ensuring cost effectiveness. Tuberculosis (TB) caused by infection with Mycobacterium bovis affects a broad range of mammalian hosts across the globe, including cattle, wildlife and humans. The control of TB in cattle in the UK and Republic of Ireland is hampered by persistent infection in European badgers (Meles meles). The present study aimed to determine the best strategy for maximising uptake of an oral vaccine by wild badgers, using a surrogate novel bait deployed at 40 badger social groups. Baits contained a blood-borne biomarker (Iophenoxic Acid, IPA) in order to measure consumption in badgers subsequently cage trapped at targeted setts. Evidence for the consumption of bait was found in 83% (199/240) of captured badgers. The probability that badgers had consumed at least one bait (IPA >10 μg ml-1) was significantly higher following deployment in spring than in summer. Lower uptake amongst social groups where more badgers were captured, suggested competition for baits. The probability of bait consumption was significantly higher at groups where main and outlier setts were provided with baits than at those where outliers were present but not baited. Badgers captured 10–14 days post bait feeding had significantly higher levels of bait uptake compared to those caught 24–28 days later. Uptake rates did not vary significantly in relation to badger age and whether bait was placed above ground or down setts. This study suggests that high levels of bait uptake can be achieved in wild badger populations and identifies factors influencing the potential success of different deployment strategies. The implications for the development of an oral badger vaccine are discussed.
    M CHAMBERS, A WILLIAMS, D GAVIER-WIDEN, A WHELAN, G HALL, P MARSH, B BLOOM, W JACOBS, R HEWINSON (2000)Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin, In: INFECTION AND IMMUNITY68pp. 7094-7099
    Alice Kent, Bernhard Ehlers, Thomas Mendum, Chris Newman, David W. Macdonald, Mark Chambers, Christina D. Buesching (2018)Genital tract screening finds widespread infection with mustelid gammaherpesvirus 1 in the European badger (Meles meles), In: Journal of Wildlife Diseases54(1)pp. 133-137 Wildlife Disease Association
    Sexually transmitted diseases (STDs) can be important drivers of population dynamics because of their negative effects on reproduction. However, screening for STDs, especially in wildlife populations, is widely neglected. Using the promiscuous, polygynandrous European badger (Meles meles) as a model, we investigated the presence and prevalence of herpesviruses (HVs) in a wild, high-density population and assessed potential differences in somatic fitness and female reproductive condition between infected and uninfected individuals. We collected n=98 genital swabs from 71 females (51 adults and 20 cubs) and 27 males (26 adults and 1 cub) during spring and summer 2015. Using a PCR specific for a mustelid α-HV, all genital-swab samples tested negative. In a panherpes PCR, a γ-HV was found in 55% (54/98; 39 adults and 15 cubs), identified as mustelid gammaherpesvirus 1 (MusGHV-1) using DNA sequencing. This contrasts with the results of a previous study, which reported MusGHV-1 in 98% (354/361) of blood samples taken from 218 badgers in the same population using PCR. The detection of MusHV-1 in the female reproductive tract strongly indicates the potential for a horizontal and, likely also a vertical, route of transmission. Our results suggest a potential linkage of genital HVs and impaired future reproductive success in females, but because reproductive failure can have many reasons in badgers, the causative link of this negative relationship remains to be investigated.
    Riccardo Manganelli, Gareth A. Williams, Marjorie E. Koenen, Robert Havenaar, Paul Wheeler, Sonya Gowtage, Sandrine Lesellier, Mark A. Chambers (2019)Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers, In: PLoS ONE14(4)e0214859 Public Library of Science
    In developing an oral bait BCG vaccine against tuberculosis in badgers we wanted to understand the conditions of the gastrointestinal tract and their impact on vaccine viability. Conditions mimicking stomach and small-intestine caused substantial reduction in BCG viability. We performed in vivo experiments using a telemetric pH monitoring system and used the data to parameterise a dynamic in vitro system (TIM-1) of the stomach and small intestine. Some BCG died in the stomach compartment and through the duodenum and jejunum compartments. BCG survival in the stomach was greatest when bait was absent but by the time BCG reached the jejunum, BCG viability was not significantly affected by the presence of bait. Our data suggest that from a starting quantity of 2.85 ± 0.45 x 108 colony-forming units of BCG around 2 log10 may be killed before delivery to the intestinal lymphoid tissue. There are economic arguments for reducing the dose of BCG to vaccinate badgers orally. Our findings imply this could be achieved if we can protect BCG from the harsh environment of the stomach and duodenum. TIM-1 is a valuable, non-animal model with which to evaluate and optimise formulations to maximise BCG survival in the gastrointestinal tract.
    H Cui, S Li, Q Yuan, A Wadhwa, S Eda, M Chambers, R Ashford, H Jiang, J Wu (2013)An AC electrokinetic impedance immunosensor for rapid detection of tuberculosis, In: ANALYST138(23)pp. 7188-7196 ROYAL SOC CHEMISTRY
    D Murphy, E Costello, FE Aldwell, S Lesellier, MA Chambers, T Fitzsimons, LA Corner, E Gormley (2014)Oral vaccination of badgers (Meles meles) against tuberculosis: comparison of the protection generated by BCG vaccine strains Pasteur and Danish., In: Vet J200(3)pp. 362-367
    Vaccination of badgers by the subcutaneous, mucosal and oral routes with the Pasteur strain of Mycobacterium bovis bacille Calmette-Guérin (BCG) has resulted in significant protection against experimental infection with virulent M. bovis. However, as the BCG Danish strain is the only commercially licensed BCG vaccine for use in humans in the European Union it is the vaccine of choice for delivery to badger populations. As all oral vaccination studies in badgers were previously conducted using the BCG Pasteur strain, this study compared protection in badgers following oral vaccination with the Pasteur and the Danish strains. Groups of badgers were vaccinated orally with 10(8) colony forming units (CFU) BCG Danish 1331 (n = 7 badgers) or 10(8) CFU BCG Pasteur 1173P2 (n = 6). Another group (n = 8) served as non-vaccinated controls. At 12 weeks post-vaccination, the animals were challenged by the endobronchial route with 6 × 10(3) CFU M. bovis, and at 15 weeks post-infection, all of the badgers were euthanased. Vaccination with either BCG strain provided protection against challenge compared with controls. The vaccinated badgers had significantly fewer sites with gross pathology and significantly lower gross pathological severity scores, fewer sites with histological lesions and fewer sites of infection, significantly lower bacterial counts in the thoracic lymph node, and lower bacterial counts in the lungs than the control group. No differences were observed between either of the vaccine groups by any of the pathology and bacteriology measures. The ELISPOT analysis, measuring production of badger interferon - gamma (IFN-γ), was also similar across the vaccinated groups.
    H VORDERMEIER, P COCKLE, A WHELAN, S RHODES, M CHAMBERS, D CLIFFORD, K HUYGEN, R TASCON, D LOWRIE, M COLSTON, R HEWINSON (2000)Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test, In: VACCINE19pp. 1246-1255
    D GAVIER-WIDEN, M CHAMBERS, N PALMER, D NEWELL, R HEWINSON (2001)Pathology of natural Mycobacterium bovis infection in European badgers (Meles meles) and its relationship with bacterial excretion, In: VETERINARY RECORD148pp. 299-+
    M CHAMBERS, A WILLIAMS, D GAVIER-WIDEN, A WHELAN, C HUGHES, G HALL, M LEVER, P MARSH, R HEWINSON (2001)A guinea pig model of low-dose Mycobacterium bovis aerogenic infection, In: VETERINARY MICROBIOLOGY80pp. 213-226
    Ioannis Sakaridis, R Ellis, S Cawthraw, Arnoud van Vliet, D Stekel, J Penell, Mark Chambers, Roberto La Ragione, Alasdair Cook (2018)Investigating the association between the caecal microbiomes of broilers and Campylobacter burden, In: Frontiers in Microbiology9927pp. 1-9 Frontiers Media
    One of the major transmission routes for the foodborne bacterial pathogen Campylobacter is undercooked poultry meat, contaminated from intestinal contents during processing. In broilers, Campylobacter can grow to very high densities in the caeca, and is often considered to be a commensal or an opportunistic pathogen in poultry. Reduction of caecal loads of Campylobacter may assist in lowering incidence rates of Campylobacter food poisoning. To achieve this, there needs to be a better understanding of the dynamics of Campylobacter colonisation in its natural niche, and the effect of the local microbiome on colonisation. Previous studies have shown that the microbiome differed between Campylobacter colonised and non–colonised chicken intestinal samples. To characterise the microbiome of Campylobacter-colonised broilers, caecal samples of 100 randomly selected birds from four farms were analysed using amplified 16S rRNA gene sequences. Bacterial taxonomic analysis indicated that inter-farm variation was greater than intra-farm variation. The two most common bacterial groups were Bacteroidetes and Firmicutes which were present in all samples and constituted 29.7 – 63.5% and 30.2 – 59.8% of the bacteria present, respectively. Campylobacter was cultured from all samples, ranging from 2 to 9 log10 CFU g-1. There was no clear link between Campylobacter counts and Firmicutes, Bacteroidetes or Tenericutes levels in the 16S rRNA Operational Taxonomic Unit (OTU)-based analysis of the caecal microbiome, but samples with high Campylobacter counts (> 9 log CFU g-1) contained increased levels of Enterobacteriaceae. A decrease in Lactobacillus abundance in chicken caeca was also associated with high Campylobacter loads. The reported associations with Lactobacillus and Enterobacteriaceae match changes in the intestinal microbiome of chickens and mice previously reported for Campylobacter infection, and raises the question about temporality and causation; as to whether increases in Campylobacter loads create conditions adverse to Lactobacilli and/or beneficial to Enterobacteriaceae, or that changes in Lactobacilli and Enterobacteriaceae levels created conditions beneficial for Campylobacter colonisation. If these changes can be controlled, this may open opportunities for modulation of chicken microbiota to reduce Campylobacter levels for improved food safety.
    Bryce Buddle, Hans Martin Vordermeier, Mark A. Chambers, Lin-Mari de Klerk-Lorist (2018)Efficacy and Safety of BCG Vaccine for Control of uberculosis in Domestic Livestock and Wildlife, In: Frontiers in Veterinary Science5 Frontiers
    Bovine tuberculosis (TB) continues to be an intractable problem in many countries, particularly where “test and slaughter” policies cannot be implemented or where wildlife reservoirs of Mycobacterium bovis infection serve as a recurrent source of infection for domestic livestock. Alternative control measures are urgently required and vaccination is a promising option. Although the M. bovis bacille Calmette-Guérin (BCG) vaccine has been used in humans for nearly a century, its use in animals has been limited, principally as protection against TB has been incomplete and vaccination may result in animals reacting in the tuberculin skin test. Valuable insights have been gained over the past 25 years to optimise protection induced by BCG vaccine in animals and in the development of tests to differentiate infected from vaccinated animals (DIVA). This review examines factors affecting the efficacy of BCG vaccine in cattle, recent field trials, use of DIVA tests and the effectiveness of BCG vaccine in other domestic livestock as well as in wildlife. Oral delivery of BCG vaccine to wildlife reservoirs of infection such as European badgers, brushtail possums, wild boar, and deer has been shown to induce protection against TB and could prove to be a practical means to vaccinate these species at scale. Testing of BCG vaccine in a wide range of animal species has indicated that it is safe and vaccination has the potential to be a valuable tool to assist in the control of TB in both domestic livestock and wildlife.
    Diane Frances Lee, Mark Andrew Chambers (2019)Isolation of Alveolar Type II Cells from Adult Bovine Lung, In: Current Protocols in Toxicology80(1)e71 John Wiley & Sons Ltd
    Alveolar type II (ATII) cells play a key role as part of the distal lung epithelium, including in the innate immune response and as self‐renewing progenitors to replace alveolar type I (ATI) cells during epithelial regeneration. Their secretion of surfactant protein helps maintain homeostasis and exerts protective, antimicrobial properties. ATII cells remain difficult to study, partly due to inefficient and expensive isolation methods, a propensity to differentiate into ATI cells, and susceptibility to fibroblast contamination. Published methods of isolation often require specialized technology, negatively impacting the development of in vitro models of disease, including bovine tuberculosis. Presented here is a simple and cost‐effective method for generation of bovine primary ATII cells. These cells exhibit an ATII phenotype in 2D and 3D culture and are conducive to further study of the role of ATII cells in bovine respiratory diseases.

    Additional publications